APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sepsis and Septic Shock Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sepsis and Septic Shock Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchSepsis and Septic Shock Treatment Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Sepsis and Septic Shock Treatment Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sepsis and Septic Shock Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sepsis and Septic Shock Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Sepsis and Septic Shock Treatment Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Sepsis and Septic Shock Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sepsis and Septic Shock Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sepsis and Septic Shock Treatment include TEVA, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer, AbbVie, Viatris and Shanghai Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Sepsis and Septic Shock Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sepsis and Septic Shock Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sepsis and Septic Shock Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sepsis and Septic Shock Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Sepsis and Septic Shock Treatment Segment by Company

TEVA

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AbbVie

Viatris

Shanghai Pharmaceuticals

NCPC

Merck & Co

INOTREM

Endacea

AtoxBio

Asahi Kasei

Adrenomed

Sepsis and Septic Shock Treatment Segment by Type

Macrolides

Pencillin

Cephalosporin

Others

Sepsis and Septic Shock Treatment Segment by Application

Sepsis

Septic Shock

Sepsis and Septic Shock Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis and Septic Shock Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sepsis and Septic Shock Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis and Septic Shock Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sepsis and Septic Shock Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sepsis and Septic Shock Treatment industry.

Chapter 3: Detailed analysis of Sepsis and Septic Shock Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis and Septic Shock Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Macrolides Table 3. Key Players of Pencillin Table 4. Key Players of Cephalosporin Table 3. Key Players of Others Table 4. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Sepsis Table 6. Key Players of Septic Shock Table 7. Global Sepsis and Septic Shock Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Sepsis and Septic Shock Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Sepsis and Septic Shock Treatment Market Share by Region (2021-2026) Table 10. Global Sepsis and Septic Shock Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Sepsis and Septic Shock Treatment Market Share by Region (2027-2032) Table 12. Sepsis and Septic Shock Treatment Industry Trends Table 13. Sepsis and Septic Shock Treatment Industry Drivers Table 14. Sepsis and Septic Shock Treatment Industry Opportunities and Challenges Table 15. Sepsis and Septic Shock Treatment Industry Restraints Table 16. Global Sepsis and Septic Shock Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Sepsis and Septic Shock Treatment Revenue Market Share by Company (2021-2026) Table 18. Global Sepsis and Septic Shock Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Sepsis and Septic Shock Treatment Key Company Head Office and Area Served Table 20. Global Sepsis and Septic Shock Treatment Company, Product Type & Application Table 21. Global Sepsis and Septic Shock Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Sepsis and Septic Shock Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Sepsis and Septic Shock Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Sepsis and Septic Shock Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2027-2032) Table 34. TEVA Company Information Table 35. TEVA Business Overview Table 36. TEVA Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. TEVA Sepsis and Septic Shock Treatment Product Portfolio Table 38. TEVA Recent Development Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Sepsis and Septic Shock Treatment Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. Novartis Company Information Table 45. Novartis Business Overview Table 46. Novartis Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Novartis Sepsis and Septic Shock Treatment Product Portfolio Table 48. Novartis Recent Development Table 49. Pfizer Company Information Table 50. Pfizer Business Overview Table 51. Pfizer Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pfizer Sepsis and Septic Shock Treatment Product Portfolio Table 53. Pfizer Recent Development Table 54. GlaxoSmithKline Company Information Table 55. GlaxoSmithKline Business Overview Table 56. GlaxoSmithKline Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. GlaxoSmithKline Sepsis and Septic Shock Treatment Product Portfolio Table 58. GlaxoSmithKline Recent Development Table 59. Bayer Company Information Table 60. Bayer Business Overview Table 61. Bayer Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Bayer Sepsis and Septic Shock Treatment Product Portfolio Table 63. Bayer Recent Development Table 64. AbbVie Company Information Table 65. AbbVie Business Overview Table 66. AbbVie Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AbbVie Sepsis and Septic Shock Treatment Product Portfolio Table 68. AbbVie Recent Development Table 69. Viatris Company Information Table 70. Viatris Business Overview Table 71. Viatris Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Viatris Sepsis and Septic Shock Treatment Product Portfolio Table 73. Viatris Recent Development Table 74. Shanghai Pharmaceuticals Company Information Table 75. Shanghai Pharmaceuticals Business Overview Table 76. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product Portfolio Table 78. Shanghai Pharmaceuticals Recent Development Table 79. NCPC Company Information Table 80. NCPC Business Overview Table 81. NCPC Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. NCPC Sepsis and Septic Shock Treatment Product Portfolio Table 83. NCPC Recent Development Table 84. Merck & Co Company Information Table 85. Merck & Co Business Overview Table 86. Merck & Co Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Merck & Co Sepsis and Septic Shock Treatment Product Portfolio Table 88. Merck & Co Recent Development Table 89. INOTREM Company Information Table 90. INOTREM Business Overview Table 91. INOTREM Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. INOTREM Sepsis and Septic Shock Treatment Product Portfolio Table 93. INOTREM Recent Development Table 94. Endacea Company Information Table 95. Endacea Business Overview Table 96. Endacea Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Endacea Sepsis and Septic Shock Treatment Product Portfolio Table 98. Endacea Recent Development Table 99. AtoxBio Company Information Table 100. AtoxBio Business Overview Table 101. AtoxBio Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. AtoxBio Sepsis and Septic Shock Treatment Product Portfolio Table 103. AtoxBio Recent Development Table 104. Asahi Kasei Company Information Table 105. Asahi Kasei Business Overview Table 106. Asahi Kasei Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Asahi Kasei Sepsis and Septic Shock Treatment Product Portfolio Table 108. Asahi Kasei Recent Development Table 109. Adrenomed Company Information Table 110. Adrenomed Business Overview Table 111. Adrenomed Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Adrenomed Sepsis and Septic Shock Treatment Product Portfolio Table 113. Adrenomed Recent Development Table 114. North America Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) Table 120. North America Sepsis and Septic Shock Treatment Market Size by Country (2027-2032) Table 121. Europe Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) Table 127. Europe Sepsis and Septic Shock Treatment Market Size by Country (2027-2032) Table 128. China Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 129. China Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 130. China Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 131. China Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) Table 138. Asia Sepsis and Septic Shock Treatment Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Sepsis and Septic Shock Treatment Product Image Figure 2. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sepsis and Septic Shock Treatment Market Share by Type: 2025 VS 2032 Figure 4. Macrolides Image Figure 5. Pencillin Image Figure 6. Cephalosporin Image Figure 7. Others Image Figure 8. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Sepsis and Septic Shock Treatment Market Share by Application: 2025 VS 2032 Figure 10. Sepsis Image Figure 11. Septic Shock Image Figure 12. Global Sepsis and Septic Shock Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Sepsis and Septic Shock Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Sepsis and Septic Shock Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Sepsis and Septic Shock Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Sepsis and Septic Shock Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Sepsis and Septic Shock Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Sepsis and Septic Shock Treatment Market Share by Type (2021-2032) Figure 25. North America Sepsis and Septic Shock Treatment Market Share by Application (2021-2032) Figure 26. North America Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 27. United States Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Sepsis and Septic Shock Treatment Market Share by Type (2021-2032) Figure 32. Europe Sepsis and Septic Shock Treatment Market Share by Application (2021-2032) Figure 33. Europe Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 34. Germany Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Sepsis and Septic Shock Treatment Market Share by Type (2021-2032) Figure 42. China Sepsis and Septic Shock Treatment Market Share by Application (2021-2032) Figure 43. Asia Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Sepsis and Septic Shock Treatment Market Share by Type (2021-2032) Figure 45. Asia Sepsis and Septic Shock Treatment Market Share by Application (2021-2032) Figure 46. Asia Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 47. Japan Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2021-2032) Figure 57. Brazil Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Sepsis and Septic Shock Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Macrolides
  • Pencillin
  • Cephalosporin
  • Others
Applications
  • Sepsis
  • Septic Shock
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Viatris
  • Shanghai Pharmaceuticals
  • NCPC
  • Merck & Co
  • INOTREM
  • Endacea
  • AtoxBio
  • Asahi Kasei
  • Adrenomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Macrolides
  5. 1.2.3 Pencillin
  6. 1.2.4 Cephalosporin
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Sepsis
  11. 1.3.3 Septic Shock
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Sepsis and Septic Shock Treatment Growth Trends by Region
  14. 1.5.1 Global Sepsis and Septic Shock Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Sepsis and Septic Shock Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Sepsis and Septic Shock Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Sepsis and Septic Shock Treatment Market Dynamics
  1. 2.1 Sepsis and Septic Shock Treatment Industry Trends
  2. 2.2 Sepsis and Septic Shock Treatment Industry Drivers
  3. 2.3 Sepsis and Septic Shock Treatment Industry Opportunities and Challenges
  4. 2.4 Sepsis and Septic Shock Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sepsis and Septic Shock Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Sepsis and Septic Shock Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sepsis and Septic Shock Treatment Key Company Head office and Area Served
  4. 3.4 Global Sepsis and Septic Shock Treatment Company, Product Type & Application
  5. 3.5 Global Sepsis and Septic Shock Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sepsis and Septic Shock Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sepsis and Septic Shock Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sepsis and Septic Shock Treatment Tier 1, Tier 2, and Tier 3
4 Sepsis and Septic Shock Treatment Market by Type
  1. 4.1 Global Sepsis and Septic Shock Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sepsis and Septic Shock Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Sepsis and Septic Shock Treatment Market Size Share by Type (2021-2032)
5 Sepsis and Septic Shock Treatment Market by Application
  1. 5.1 Global Sepsis and Septic Shock Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sepsis and Septic Shock Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Sepsis and Septic Shock Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 TEVA
  2. 6.1.1 TEVA Company Information
  3. 6.1.2 TEVA Business Overview
  4. 6.1.3 TEVA Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 TEVA Sepsis and Septic Shock Treatment Product Portfolio
  6. 6.1.5 TEVA Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Sepsis and Septic Shock Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Sepsis and Septic Shock Treatment Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Sepsis and Septic Shock Treatment Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Sepsis and Septic Shock Treatment Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer Sepsis and Septic Shock Treatment Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AbbVie Sepsis and Septic Shock Treatment Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viatris Sepsis and Septic Shock Treatment Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Shanghai Pharmaceuticals
  50. 6.9.1 Shanghai Pharmaceuticals Company Information
  51. 6.9.2 Shanghai Pharmaceuticals Business Overview
  52. 6.9.3 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product Portfolio
  54. 6.9.5 Shanghai Pharmaceuticals Recent Developments
  55. 6.10 NCPC
  56. 6.10.1 NCPC Company Information
  57. 6.10.2 NCPC Business Overview
  58. 6.10.3 NCPC Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 NCPC Sepsis and Septic Shock Treatment Product Portfolio
  60. 6.10.5 NCPC Recent Developments
  61. 6.11 Merck & Co
  62. 6.11.1 Merck & Co Company Information
  63. 6.11.2 Merck & Co Business Overview
  64. 6.11.3 Merck & Co Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Merck & Co Sepsis and Septic Shock Treatment Product Portfolio
  66. 6.11.5 Merck & Co Recent Developments
  67. 6.12 INOTREM
  68. 6.12.1 INOTREM Company Information
  69. 6.12.2 INOTREM Business Overview
  70. 6.12.3 INOTREM Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 INOTREM Sepsis and Septic Shock Treatment Product Portfolio
  72. 6.12.5 INOTREM Recent Developments
  73. 6.13 Endacea
  74. 6.13.1 Endacea Company Information
  75. 6.13.2 Endacea Business Overview
  76. 6.13.3 Endacea Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Endacea Sepsis and Septic Shock Treatment Product Portfolio
  78. 6.13.5 Endacea Recent Developments
  79. 6.14 AtoxBio
  80. 6.14.1 AtoxBio Company Information
  81. 6.14.2 AtoxBio Business Overview
  82. 6.14.3 AtoxBio Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AtoxBio Sepsis and Septic Shock Treatment Product Portfolio
  84. 6.14.5 AtoxBio Recent Developments
  85. 6.15 Asahi Kasei
  86. 6.15.1 Asahi Kasei Company Information
  87. 6.15.2 Asahi Kasei Business Overview
  88. 6.15.3 Asahi Kasei Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Asahi Kasei Sepsis and Septic Shock Treatment Product Portfolio
  90. 6.15.5 Asahi Kasei Recent Developments
  91. 6.16 Adrenomed
  92. 6.16.1 Adrenomed Company Information
  93. 6.16.2 Adrenomed Business Overview
  94. 6.16.3 Adrenomed Sepsis and Septic Shock Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Adrenomed Sepsis and Septic Shock Treatment Product Portfolio
  96. 6.16.5 Adrenomed Recent Developments
7 North America
  1. 7.1 North America Sepsis and Septic Shock Treatment Market Size (2021-2032)
  2. 7.2 North America Sepsis and Septic Shock Treatment Market Size by Type
  3. 7.2.1 North America Sepsis and Septic Shock Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Sepsis and Septic Shock Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Sepsis and Septic Shock Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Sepsis and Septic Shock Treatment Market Size by Application
  7. 7.3.1 North America Sepsis and Septic Shock Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Sepsis and Septic Shock Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Sepsis and Septic Shock Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Sepsis and Septic Shock Treatment Market Size by Country
  11. 7.4.1 North America Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Sepsis and Septic Shock Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Sepsis and Septic Shock Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sepsis and Septic Shock Treatment Market Size (2021-2032)
  2. 8.2 Europe Sepsis and Septic Shock Treatment Market Size by Type
  3. 8.2.1 Europe Sepsis and Septic Shock Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sepsis and Septic Shock Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sepsis and Septic Shock Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Sepsis and Septic Shock Treatment Market Size by Application
  7. 8.3.1 Europe Sepsis and Septic Shock Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sepsis and Septic Shock Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sepsis and Septic Shock Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Sepsis and Septic Shock Treatment Market Size by Country
  11. 8.4.1 Europe Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sepsis and Septic Shock Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sepsis and Septic Shock Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sepsis and Septic Shock Treatment Market Size (2021-2032)
  2. 9.2 China Sepsis and Septic Shock Treatment Market Size by Type
  3. 9.2.1 China Sepsis and Septic Shock Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Sepsis and Septic Shock Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Sepsis and Septic Shock Treatment Market Share by Type (2021-2032)
  6. 9.3 China Sepsis and Septic Shock Treatment Market Size by Application
  7. 9.3.1 China Sepsis and Septic Shock Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Sepsis and Septic Shock Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Sepsis and Septic Shock Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sepsis and Septic Shock Treatment Market Size (2021-2032)
  2. 10.2 Asia Sepsis and Septic Shock Treatment Market Size by Type
  3. 10.2.1 Asia Sepsis and Septic Shock Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sepsis and Septic Shock Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sepsis and Septic Shock Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Sepsis and Septic Shock Treatment Market Size by Application
  7. 10.3.1 Asia Sepsis and Septic Shock Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sepsis and Septic Shock Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sepsis and Septic Shock Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Sepsis and Septic Shock Treatment Market Size by Country
  11. 10.4.1 Asia Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sepsis and Septic Shock Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sepsis and Septic Shock Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst